Since the release of the "Eight Measures for Deepening the Reform of the Science and Technology Innovation and the Development of New Quality Production" (referred to as the "Star Eight Measures") more than two months ago, companies such as Shanghai Microport Endovascular Medtech(Group)Co.,Ltd., Xinlian Integrated Circuit Co., Ltd., Nanxin Micro, Jiangsu Aidea Pharmaceutical, Fuchuang Precision, Xidi Micro, and Zejing Pharmaceutical have successively released industrial merger and acquisition plans. Typical cases of mergers and acquisitions in the fields of semiconductors and biomedical have emerged one after another. Industry insiders believe that the Star Market is gradually becoming a gathering place for domestic semiconductor listed companies, and the biomedical industry cluster is also developing rapidly. The introduction of the "Star Eight Measures" has further unleashed the vitality of the merger and reorganization market, and more hard technology companies have used merger and reorganization tools to achieve effective industrial integration and high-quality development. (Shanghai Securities News)